Canada - English - Health Canada

centre for probe development and commercialization - fludeoxyglucose 18f - solution - 157gbq - fludeoxyglucose 18f 157gbq - roentgenography

Canada - English - Health Canada

centre for probe development and commercialization - fludeoxyglucose 18f - solution - 453gbq - fludeoxyglucose 18f 453gbq - roentgenography

United States - English - NLM (National Library of Medicine)

decatur memorial hospital - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f18 injection, usp is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none. data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data ). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. howeve

United States - English - NLM (National Library of Medicine)

barbara ann karmanos cancer hospital - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f 18 injection is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none risk summary data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose.

Canada - English - Health Canada

centre for probe development and commercialization - fludeoxyglucose 18f - solution - 540gbq - fludeoxyglucose 18f 540gbq - roentgenography

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - fludeoxyglucose (18f) - solution for injection - 250 mbg/ml

United States - English - NLM (National Library of Medicine)

northland nuclear medicine - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f 18 injection,usp is indicated in pet (positron emission tomography) for: 1. identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. 2. assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. 3. assessment of patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging, for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function. fludeoxyglucose f 18 injection, usp is not indicated for distinguishing epileptogenic foci from brain tumors or other brain lesions which may cause seizures. none known

Canada - English - Health Canada

thunder bay regional health sciences centre - fludeoxyglucose 18f - solution - fludeoxyglucose 18f 0.5 gbq / vial - other diagnostic radiopharm. for tumor detection

Singapore - English - HSA (Health Sciences Authority)

singapore radiopharmaceuticals pte. ltd. - 2-deoxy-2-[18f]fluoro-d-glucose - injection, solution - 5-200mci/ml - 2-deoxy-2-[18f]fluoro-d-glucose 5-200mci/ml